A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : BAL / biphenotypic acute leukemia

[Related PubMed/MEDLINE]
Total Number of Papers: 53
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   BAL  (>> Co-occurring Abbreviation)
Long Form:   biphenotypic acute leukemia
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Biphenotypic acute leukemia or acute leukemia of ambiguous lineage in childhood: clinical characteristics and outcome. AL, AUL, EFS, EGIL, MPAL, OS, WHO
2018 Biphenotypic Acute Leukemia versus Myeloid Antigen-Positive ALL: Clinical Relevance of WHO Criteria for Mixed Phenotype Acute Leukemia. MPAL, MPO
2017 Genetically engineered mesenchymal stromal cells produce IL-3 and TPO to further improve human scaffold-based xenograft models. ALL, AML, BM, CB, IL-3, MSCs, TPO
2016 Co-occurrence of biphenotypic acute leukaemia, glucose 6-phosphate dehydrogenase deficiency and haemoglobin E trait in a single child. G6-PD
2016 Outcomes of allogeneic hematopoietic cell transplantation in patients with biphenotypic acute leukemia. ALL, AML, HSCT, OS
2016 Relapse of Biphenotypic Acute Leukemia as a Breast Mass. ---
2015 T-cell acute lymphoid leukemia resembling Burkitt leukemia cell morphology: A case report. CD, EGIL, T-ALL
2014 Polycythemia vera transforming to myelofibrosis and then biphenotype acute leukemia. MF, MPN, PV
2014 [Clinical study on role of CD34 in patients with Biphenotypic acute leukemia]. ALL, AML, McAb
10  2013 Acute leukemias of ambiguous lineage in adults: molecular and clinical characterization. AML, AUL, SCT, T-ALL
11  2013 Biphenotypic Acute Leukemia with t(15;17) Lacking Promyelocytic-retinoid Acid Receptor alpha Rearrangement. WBC
12  2013 Gene expression profiling of the DNMT3A R882 mutation in acute leukemia. ALL, AML, DNMT3A
13  2013 Lineage classification of childhood acute lymphoblastic leukemia according to the EGIL recommendations: results of the ALL-BFM 2000 trial. FCM, MRD
14  2011 Clinical characteristics, biological profile, and outcome of biphenotypic acute leukemia: a case series. ALL, AML
15  2011 Immunophenotypic characterization of acute leukemia at a public oncology reference center in Maranhao, northeastern Brazil. AL, ALL, AML
16  2011 Incidence of Philadelphia-chromosome in acute myelogenous leukemia and biphenotypic acute leukemia patients: And its role in their outcome. ---
17  2011 [Immunophenotyping characteristics of biphenotypic acute leukemia and analysis of curative effect]. CR, EGIL
18  2010 [Therapeutic results in patients with biphenotypic acute leukemia at Sapporo Medical University Hospital]. ALL, AML, EGIL
19  2009 Acute leukemia of ambiguous lineage, biphenotype, without CD34, TdT or TCR-rearrangement. ---
20  2009 Biphenotypic acute leukemia treated with acute myeloid leukemia regimens: a case series. AML
21  2009 Clinico-hematological profile in biphenotypic acute leukemia. CML, CR, EGIL's
22  2009 Diagnosis of biphenotypic acute leukemia: a paradigmatic approach. ALL, EGIL, WHO
23  2009 Immunophenotypic profile of acute leukemia: critical analysis and insights gained at a tertiary care center in India. AL, ALL, AML, AUL, CML-BC
24  2009 Outcomes of CAG regimen for refractory biphenotypic acute leukemia patients. CAG
25  2009 Stem cell transplant in the treatment of childhood biphenotypic acute leukemia. HSCT
26  2009 [Biphenotypic acute leukaemia with Burkitt-like cytology]. EGIL
27  2009 [Clinical characteristics and outcomes of 59 patients with acute lymphoblastic leukemia positive for BCR/ABL]. allo-HSCT, CR, WBC
28  2009 [Study on the clinical characteristics of adult biphenotypic acute leukaemia]. ALL, AML, CR
29  2008 B-Lymphoid and myeloid lineages biphenotypic acute leukemia with t(8;21)(q22;q22). ---
30  2008 Biological features and outcome of biphenotypic acute leukemia: a case series. CR, EGIL
31  2008 Prognostic implications of the immunophenotype in biphenotypic acute leukemia. ---
32  2008 [Biphenotypic and bilineal acute leukemias]. AL, EGIL
33  2007 Biphenotypic acute leukaemia: a case series. ALL, AML, CR
34  2007 Transforming activity of purinergic receptor P2Y, G protein coupled, 8 revealed by retroviral expression screening. P2RY8
35  2007 [Clinical study on prognosis of acute leukemia subtypes Ly + AML and My + ALL]. AL, ALL, AML
36  2006 Cytogenetics, molecular and ultrastructural characteristics of biphenotypic acute leukemia identified by the EGIL scoring system. AL, EGIL
37  2006 IgH and TCRgamma gene rearrangements, cyclin A1 and HOXA9 gene expression in biphenotypic acute leukemias. ALL, AML
38  2006 [Biphenotypic Acute Leukemia with BCR-ABL mRNA Transcript b3a2 Type: A Case Report with Review of the Literature.]. ---
39  2006 [Combination of interphase- and metaphase-fluorescence in situ hybridization to identify 11q23/MLL abnormalities in acute leukemia patients]. AL, dmin, FISH, HSR, pro-B ALL
40  2005 Biphenotypic acute leukemia with t(15;17). FISH
41  2005 CD79a expression in acute myeloid leukemia t(8;21) and the importance of cytogenetics in the diagnosis of leukemias with immunophenotypic ambiguity. FISH
42  2004 Biphenotypic acute leukemia: a case report. IgH, TdT, WHO
43  2004 Pro-T ALL: immunophenotypical analyses. ALL
44  2003 A novel c-kit positive biphenotypic acute leukemia cell line, TMBL-1, carrying a p53 point mutation. IL-7, SCF
45  2002 Development of a transient monoclonal gammopathy after chemotherapy in a patient with biphenotypic acute leukemia. ---
46  2000 [Study on the clinical characteristics of biphenotypic acute leukemia]. CR
47  1999 Enhanced myeloid specificity of CD117 compared with CD13 and CD33. ALL, AML
48  1998 Adult biphenotypic acute leukaemia: an entity with poor prognosis which is related to unfavourable cytogenetics and P-glycoprotein over-expression. ALL, AML
49  1998 Establishment and characterization of "biphenotypic" acute leukemia cell lines with a variant Ph translocation t(9;22;10) (q34;q11;q22). ALL, bcr, CML, PCR
50  1998 The reliability and specificity of c-kit for the diagnosis of acute myeloid leukemias and undifferentiated leukemias. The European Group for the Immunological Classification of Leukemias (EGIL). ALL, AML, EGIL, FAB
51  1997 Allogeneic bone marrow transplant in pediatric patients with high-risk hematopoietic malignancies early in the course of their disease. ALL, ANLL, BMT, CML, CR, EFS, FTBI
52  1997 Definition of acute biphenotypic leukemia. ALL, AML, EGIL
53  1995 Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). ALL, AML, EGIL